Liver-Directed Knockout and Transgene Delivery of Arginase-1 in Mice

被引:0
|
作者
Funk, Colin D. [1 ]
Ballantyne, Laurel [1 ]
Schulze, Andreas [2 ]
机构
[1] Queens Univ, Biomed & Mol Sci, Kingston, ON, Canada
[2] Hosp Sick Children, Toronto, ON, Canada
来源
FASEB JOURNAL | 2016年 / 30卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1025.1
引用
收藏
页数:1
相关论文
共 50 条
  • [41] AAV-mediated liver-directed homology-independent targeted integration provides stable therapeutic levels of transgene expression in newborn mice with a lysosomal storage disease.
    Ferla, R.
    Llado-Santaeularia, M.
    Dell'Anno, M.
    Esposito, F.
    Pone, E.
    Minopoli, R.
    Minopoli, R.
    Iodice, C.
    Nusco, E.
    Nusco, E.
    Lyubenova, H.
    Manfredi, A.
    Difilippo, L.
    Iuliano, A.
    Torella, A.
    Piluso, G.
    Musacchia, F.
    Cacchiarelli, D.
    Nigro, V.
    Auricchio, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A64 - A65
  • [42] Limited transgene immune response and long-term expression of human α-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy
    Di Domenico, C.
    Di Napoli, D.
    Gonzalez y Reyero, E.
    Lombardo, A.
    Naldini, L.
    Di Natale, P.
    HUMAN GENE THERAPY, 2006, 17 (11) : 1112 - 1121
  • [43] Liver-Directed Gene Therapy for Lung Disease in Alpha1 Antitrypsin Deficiency
    Zieger, Marina
    Greer, Cynthia
    Flotte, Terence R.
    Mueller, Christian
    MOLECULAR THERAPY, 2020, 28 (04) : 572 - 572
  • [44] Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice
    Tsukamoto, K
    Tangirala, R
    Chun, SH
    Puré, E
    Rader, DJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (09) : 2162 - 2170
  • [45] LIVER-DIRECTED GENE THERAPY RESULTS IN THE PERMANENT REVERSAL OF AUTOIMMUNE DIABETES IN NON OBESE DIABETIC MICE
    Ren, Binhai
    O'Brien, Bronwyn A.
    Byrne, Michelle
    Ch'ng, Edwin
    Swan, M. Anne
    Gijsbers, Rik
    Debyser, Zeger
    Simpson, Ann M.
    JOURNAL OF GENE MEDICINE, 2009, 11 (09): : 845 - 845
  • [46] Neonatal liver-directed gene therapy markedly reduces bone disease in MPS 1
    Liu, YL
    Robert, M
    Xu, LF
    Novack, D
    Semenkovich, C
    Coleman, T
    Ponder, K
    MOLECULAR THERAPY, 2004, 9 : S325 - S325
  • [47] T cell responses to AAV vector capsid limit the duration of transgene expression in humans after liver-directed gene therapy.
    Mingozzi, F
    Maus, MV
    Sabatino, DE
    Hui, D
    Manno, CS
    Ragni, MV
    High, KA
    BLOOD, 2005, 106 (11) : 855A - 855A
  • [48] Liver-directed Gene Expression Using Recombinant AAV 2/8 Vectors - a Tolerogenic Strategy for Gene Delivery?
    Sharland, Alexandra
    Logan, Grant J.
    Bishop, Alex
    Alexander, Ian E.
    DISCOVERY MEDICINE, 2010, 9 (49) : 519 - 527
  • [49] Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver
    Geramizadeh, Bita
    Seirfar, Nasibe
    HEPATITIS MONTHLY, 2015, 15 (07)
  • [50] Macrophage/neutrophil specific Arginase-1 is a critical survival factor and regulator of liver fibrosis during Schistosoma mansoni infection
    Pesce, John T.
    Cheever, Allen W.
    Ramalingam, Thirumalai R.
    Wilson, Mark S.
    Mentink-Kane, Margaret M.
    El Kasmi, Karim C.
    Smith, Amber M.
    Murray, Peter J.
    Wynn, Thomas A.
    FASEB JOURNAL, 2008, 22